Diabetes Technology: Science and Practice

We live in a century of technological revolution and the birth of artificial intelligence. Like every other sphere of our life, diabetes-related technology is moving forward with lightning speed. New and improved insulin administration devices, increased capacity for monitoring one's blood glucose levels, and the ability to communicate directly with the device supplying insulin as well as with the patient and his/her healthcare provider have changed diabetes therapy forever. The problem is that diabetes-related technology is moving ahead much faster than physicians and other healthcare professionals can incorporate these advances into our practices. Diabetes Technology will consist of three parts: Part I addresses the clinical science of diabetes pumps, continuous glucose monitoring and communication technology with numerous practical aspects. Part III offers personal stories of healthcare providers who treat their own diabetes with modern diabetes technology. In particular, they will address how and why they decided to use this technology and the positive and negative aspects of their decision.

Boris Draznin, MD, PhD, is an internationally known leader in the field of diabetes research and clinical practice. At present, he is the Director of the Adult Diabetes Program and the Celeste and Jack Grynberg Professor of Medicine at the University of Colorado, Denver. On average, his Program oversees the clinical care of three new patients every day, seven days a week, 365 days a year for a total of over 1,000 new diabetes patients each year. He has served as Chair of the Professional Section Advisory Panel of the American Diabetes Association and President of the Western Association of Physicians. Dr. Draznin has authored or co-authored 150 articles in the peer-reviewed literature and has accepted invitations to edit or submit chapters to over 20 books. He has written for professional audiences as well as the general public.